Literature DB >> 11147894

Surveillance neuroimaging in childhood intracranial ependymoma: how effective, how often, and for how long?

C D Good1, A M Wade, R D Hayward, K P Phipps, A J Michalski, W F Harkness, W K Chong.   

Abstract

OBJECT: The authors examined images obtained in 52 children with intracranial ependymomas to determine risk factors for tumor recurrence and to assess the impact of surveillance imaging on patient outcome.
METHODS: Data obtained in all children with intracranial ependymomas were prospectively entered into a database from January 1987 to June 2000. The imaging and clinical details in all patients were reviewed. Fifty-two children with histologically proven intracranial ependymomas were treated at the authors' institution; recurrences developed in 28 (54%) of them, with a median time from surgery to first recurrence of 14.5 months (range 3-65 months). Of these tumor recurrences, 43% were asymptomatic and were noted on surveillance imaging. Seventeen children died, all of whom had recurrences. Incomplete excision of the primary tumor was significantly associated with reduced time to recurrence (p = 0.0144) and time to death (p = 0.0472). The age of the patient, location of the primary tumor, histological findings, and the presence or absence of spinal metastases on preoperative imaging were not significantly associated with outcome. The risk of death at any given time was 12-fold greater in patients in whom a recurrence was identified due to symptoms rather than on surveillance images (p = 0.016).
CONCLUSIONS: Recurrent childhood ependymoma has a poor prognosis. The extent of the initial local tumor resection is the factor most closely associated with outcome. Surveillance imaging reveals a substantial number of asymptomatic recurrences, and survival appears to be improved in these patients compared with those identified by symptoms. The improvement in survival is thought to be greater than that expected just from earlier diagnosis.

Entities:  

Mesh:

Year:  2001        PMID: 11147894     DOI: 10.3171/jns.2001.94.1.0027

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

1.  Introduction to seminar in radiation dose reduction.

Authors:  Thomas L Slovis
Journal:  Pediatr Radiol       Date:  2002-08-29

2.  Spontaneous regression of residual low-grade cerebellar pilocytic astrocytomas in children.

Authors:  Roxana S Gunny; Richard D Hayward; Kim P Phipps; Brian N Harding; Dawn E Saunders
Journal:  Pediatr Radiol       Date:  2005-07-27

3.  Posterior fossa ependymomas: new radiological classification with surgical correlation.

Authors:  Jean Marie U-King-Im; Michael D Taylor; Charles Raybaud
Journal:  Childs Nerv Syst       Date:  2010-08-03       Impact factor: 1.475

4.  Late dissemination of fourth ventricle ependymoma: a case report.

Authors:  S Nakasu; M Ohashi; F Suzuki; M Matsuda
Journal:  J Neurooncol       Date:  2001-11       Impact factor: 4.130

5.  Multiple spinal cord recurrences of an intracranial ependymoma after 14 years.

Authors:  Semie Hong; Woo Jin Choe; Chang Taek Moon
Journal:  J Korean Neurosurg Soc       Date:  2013-12-31

6.  Late spinal cord metastasis of fourth ventricle ependymoma appeared nineteen years after the initial treatment.

Authors:  Hidenobu Ochiai; Yuzo Yamakawa; Hirokazu Kawano; Yoshiya Shimao; Tohru Hayashi
Journal:  J Neurooncol       Date:  2009-07-21       Impact factor: 4.130

Review 7.  Ependymomas.

Authors:  Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

Review 8.  Management strategies for recurrent ependymoma in the paediatric population.

Authors:  M Sangra; N Thorp; P May; B Pizer; C Mallucci
Journal:  Childs Nerv Syst       Date:  2009-05-30       Impact factor: 1.475

9.  Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults.

Authors:  Anna L Marsland; Peter J Gianaros; Sarah M Abramowitch; Stephen B Manuck; Ahmad R Hariri
Journal:  Biol Psychiatry       Date:  2008-06-02       Impact factor: 13.382

10.  Immunohistochemical markers for prognosis of ependymal neoplasms.

Authors:  Andrey Korshunov; Andrey Golanov; Valery Timirgaz
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.